- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/07 - Bacillus
Détention brevets de la classe A61K 39/07
Brevets de cette classe: 287
Historique des publications depuis 10 ans
|
22
|
29
|
26
|
16
|
15
|
15
|
13
|
11
|
15
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19839 |
10 |
| Bayer Cropscience LP | 365 |
7 |
| The Regents of the University of Michigan | 4676 |
7 |
| Altimmune Inc | 25 |
7 |
| Spogen Biotech Inc. | 130 |
7 |
| The Trustees of the University of Pennsylvania | 4315 |
5 |
| Horizon Technology Finance Corporation | 24 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
5 |
| Himv LLC | 29 |
5 |
| President and Fellows of Harvard College | 5952 |
4 |
| The Johns Hopkins University | 5642 |
3 |
| Dynavax Technologies Corporation | 116 |
3 |
| Emergent BioSolutions Inc. | 37 |
3 |
| Ganeden Biotech, Inc. | 54 |
3 |
| Molecular Express, Inc. | 13 |
3 |
| PharmAthene, Inc. | 10 |
3 |
| Phico Therapeutics Ltd. | 22 |
3 |
| Soligenix, Inc. | 52 |
3 |
| The Texas a & M University System | 1680 |
3 |
| Texas Tech University System | 569 |
3 |
| Autres propriétaires | 195 |